Back to SO SOFTBANK GROUP CORP.

RXRXRXRX
7 quarters

Position history for SOSOFTBANK GROUP CORP.'s holdings in RECURSION PHARMACEUTICALS IN

SOFTBANK GROUP CORP. holds 13.6M shares of RXRX (RECURSION PHARMACEUTICALS IN), worth $50M as of 2026-Q2. RXRX represents 0.3% of SOFTBANK GROUP CORP.'s portfolio.

Current Value

$50M

Current Shares

13.6M

Total Value Change

-$49.1M

Total Shares Change

-1M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Unchanged
13.6M
0.0%
$50M0.3%$3.67
0
2026-Q1
Unchanged
13.6M
0.0%
$41.9M0.4%$3.54
0
2025-Q4
Decreased
13.6M
-7.0%
$55.8M0.4%$4.11
0
2025-Q3
Unchanged
14.7M
0.0%
$71.6M0.3%$4.91
0
2025-Q2
Unchanged
14.7M
0.0%
$74.2M0.3%$5.03
0
2025-Q1
Unchanged
14.7M
0.0%
$77.6M0.3%$5.81
0
2024-Q4
New
14.7M
-
$99.2M0.4%$6.77
51

Other major holders of RXRX: BAILLIE GIFFORD & CO, ARK Investment Management LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used